Literature DB >> 20598898

Pathological finding of subclinical interstitial pneumonia as a predictor of postoperative acute respiratory distress syndrome after pulmonary resection.

Hajime Saito1, Yoshihiro Minamiya, Hiroshi Nanjo, Manabu Ito, Takashi Ono, Satoru Motoyama, Manabu Hashimoto, Jun-ichi Ogawa.   

Abstract

OBJECTIVE: Post-surgical interstitial pneumonia (IP) is a part of postoperative acute respiratory distress syndrome (ARDS). Some cases of ARDS may be an acute exacerbation of idiopathic pulmonary fibrosis (IPF) that is generally not recognised as IPF prior to surgery. In this study, we evaluated IP on preoperative computed tomography (CT) and histopathological findings in patients who underwent thoracic surgery, and attempted to identify high-risk patients who might develop postoperative ARDS.
METHODS: A retrospective review of preoperative CT and histopathological examination was performed in 487 patients who underwent lobectomy for primary lung cancer at our institute.
RESULTS: The incidence of ARDS was 2.05%, and histopathological finding of IP was the only predictor of ARDS (P = 0.038, odds ratio (OR) = 6.89). The incidence of IP on histopathological examination was 9.7% for all cases of lung cancer; and the incidence of ARDS in the IP-positive group (31.8%) was significantly different from that in the IP-negative group (1.5%) (P<0.05). However, in 85.7% of patients with ARDS, who were histologically IP-positive, IP was masked by emphysematous findings and thus not detected on preoperative CT.
CONCLUSIONS: In this study, histopathological finding of IP was the only predictor of ARDS; however, it was difficult to identify preoperatively because emphysematous change was also present in the majority of cases, which masks the findings of IP on CT. If identification of the high-risk case of ARDS is insisted upon, screening the presence or absence of IP (e.g., just in the patients with emphysema or IP finding on CT) by histopathological examination, as the need arises, after surgery using resected lung might be one of the additional methods of identifying those at high risk of ARDS.
Copyright © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20598898     DOI: 10.1016/j.ejcts.2010.05.017

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  12 in total

Review 1.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 2.  Combined pulmonary fibrosis and emphysema (CPFE): an entity different from emphysema or pulmonary fibrosis alone.

Authors:  Huijin Lin; Shanping Jiang
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

Review 3.  Combined pulmonary fibrosis and emphysema syndrome: a review.

Authors:  Matthew D Jankowich; Sharon I S Rounds
Journal:  Chest       Date:  2012-01       Impact factor: 9.410

4.  The worst of both worlds-combined pulmonary fibrosis and emphysema syndrome.

Authors:  Sheeba Habeeb Ba Aqeel; Abhishek Biswas; Peruvemba S Sriram
Journal:  Ann Transl Med       Date:  2016-05

5.  Acute exacerbation of subclinical pulmonary fibrosis after red blood cell transfusion: a case report.

Authors:  Matthew Woodske; Michael P Donahoe; Mark Yazer; Janet S Lee
Journal:  Transfusion       Date:  2011-08-09       Impact factor: 3.157

6.  Incidental nonneoplastic parenchymal findings in patients undergoing lung resection for mass lesions.

Authors:  Yin P Hung; Gary M Hunninghake; Ezra R Miller; Rachel Putman; Mizuki Nishino; Tetsuro Araki; Hiroto Hatabu; Lynette M Sholl; Marina Vivero
Journal:  Hum Pathol       Date:  2019-01-15       Impact factor: 3.466

7.  Pulmonary radiofrequency ablation complicated by acute respiratory distress syndrome.

Authors:  C Reilly; Kent T Sato
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

8.  An increased risk of lung cancer in combined pulmonary fibrosis and emphysema patients with usual interstitial pneumonia compared with patients with idiopathic pulmonary fibrosis alone: a systematic review and meta-analysis.

Authors:  Qianqian Chen; Ping Liu; Hong Zhou; Hui Kong; Weiping Xie
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031

9.  Imaging diagnosis of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema).

Authors:  Fumikazu Sakai; Junya Tominaga; Akiko Kaga; Yutaka Usui; Minoru Kanazawa; Takashi Ogura; Noriyo Yanagawa; Tamiko Takemura
Journal:  Pulm Med       Date:  2012-02-09

10.  Pembrolizumab-induced interstitial lung disease following thoracic surgery in a patient with non-small cell lung cancer.

Authors:  Tetsuo Fujita; Nami Hayama; Tsuguko Kuroki; Yuka Shiraishi; Hiroyuki Amano; Makoto Nakamura; Satoshi Hirano; Nao Aramaki; Shuji Ichinose; Shinichiro Shimizu; Hiroshi Tabeta; Sukeyuki Nakamura
Journal:  Thorac Cancer       Date:  2019-09-11       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.